Therapy of hepatitis C in thalassemia: the influence of iron on achieving sustained viral response

被引：5
作者：
Alavian, Seyed-Moayed [1 ,2 ]
Tabatabaei, Seyed-Vahid [2 ]
机构：
[1] Grand Floor Baqiyatallah Hosp, Baqiyatallah Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
[2] Baqiyatallah Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
来源：
ANNALS OF HEMATOLOGY | 2010年 / 89卷 / 02期
关键词：
INTERFERON-ALPHA THERAPY; BETA-THALASSEMIA; INFECTION; RIBAVIRIN;
D O I：
10.1007/s00277-009-0785-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 12 条
  • [1] Interferon alpha monotherapy for chronic hepatitis C viral infection in thalassemics and hemodialysis patients
    Artan, R
    Akcam, M
    Yilmaz, A
    Kocacik, D
    [J]. JOURNAL OF CHEMOTHERAPY, 2005, 17 (06) : 651 - 655
  • [2] Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: A meta-analysis of six prospective randomized controlled trials
    Desai, Tusar K.
    Jamil, Laith H.
    Balasubramaniam, Mamtha
    Koff, Raymond
    Bonkovsky, Herbert L.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (03) : 815 - 822
  • [3] Liver iron influences the response to interferon alpha therapy in chronic hepatitis C
    Fargion, S
    Fracanzani, AL
    Sampietro, M
    Molteni, V
    Boldorini, R
    Mattioli, M
    Cesana, B
    Lunghi, G
    Piperno, A
    Valsecchi, C
    Fiorelli, G
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (05) : 497 - 503
  • [4] Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
    Fontana, RJ
    Israel, J
    LeClair, P
    Banner, BF
    Tortorelli, K
    Grace, N
    Levine, RA
    Fiarman, G
    Thiim, M
    Tavill, AS
    Bonkovsky, HL
    [J]. HEPATOLOGY, 2000, 31 (03) : 730 - 736
  • [5] Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype
    Gehrke, SG
    Stremmel, W
    Mathes, I
    Riedel, HD
    Bents, K
    Kallinowski, B
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (12): : 780 - 787
  • [6] Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia
    Harmatz, Paul
    Jonas, Maureen M.
    Kwiatkowski, Janet L.
    Wright, Elizabeth C.
    Fischer, Roland
    Vichinsky, Elliott
    Giardina, Patricia J.
    Neufeld, Ellis J.
    Porter, John
    Olivieril, Nancy
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08): : 1247 - 1251
  • [7] HEPATIC IRON CONCENTRATION AS A PREDICTOR OF RESPONSE TO INTERFERON-ALFA THERAPY IN CHRONIC HEPATITIS-C
    OLYNYK, JK
    REDDY, KR
    DIBISCEGLIE, AM
    JEFFERS, LJ
    PARKER, TI
    RADICK, JL
    SCHIFF, ER
    BACON, BR
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : 1104 - 1109
  • [8] Sievert W, 2002, AM J GASTROENTEROL, V97, P982
  • [9] Response to interferon alfa-2b therapy in multitransfused children with beta-thalassemia and chronic hepatitis C
    Spiliopoulou, I
    Repanti, M
    Katinakis, S
    Karana-Ginopoulou, A
    Papanastasiou, DA
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) : 709 - 715
  • [10] Syriopoulou V, 2005, HAEMATOLOGICA, V90, P129
12